文献速递产科母胎医学

12周前启动低剂量阿司匹林可改善中子痫前期中危孕妇妊娠结局

Early initiation of low-dose aspirin before 12 weeks improves pregnancy outcomes in women with moderate-risk factors for preeclampsia.
PubMed 文献 · Am J Obstet Gynecol MFM · 2026-08-13

本回顾性队列研究纳入2015至2025年间单中心分娩的、具有至少两项子痫前期中危因素且孕期每日服用低剂量阿司匹林(LDA)的单胎孕妇,比较12周前启动(n=1802)与12至20周启动(n=473)的母儿结局。结果显示,早期启动与妊娠期高血压、子痫前期、妊娠期糖尿病、32周前早产、5分钟低Apgar评分及新生儿重症监护病房入住风险显著降低相关。

要点

  • 12周前启动LDA与子痫前期风险显著降低相关(aOR 0.29,95%CI 0.20-0.42)。
  • 早期启动还与妊娠期高血压、妊娠期糖尿病及32周前早产风险降低相关。
  • 新生儿结局改善,包括5分钟低Apgar评分和NICU入住风险降低。

核心结论

  • 对于具有至少两项子痫前期中危因素的孕妇,12周前启动LDA与妊娠期高血压疾病、早产及新生儿发病率风险降低相关。

研究设计与样本

  • 回顾性队列研究,纳入2015至2025年间单中心分娩的、至少两项子痫前期中危因素且孕期每日服用LDA的单胎孕妇,排除子痫前期高危因素者。
  • 按阿司匹林启动时机分为12周前启动组(n=1802)和12至20周启动组(n=473)。
  • 采用多变量logistic回归分析,调整母亲年龄、体重指数、产次和受孕方式。

主要发现

  • 妊娠期高血压发生率:早期启动组110/1802(6.1%) vs 晚期启动组118/473(24.9%),aOR 0.24,95%CI 0.18-0.33。
  • 子痫前期发生率:75/1802(4.2%) vs 74/473(15.6%),aOR 0.29,95%CI 0.20-0.42。
  • 妊娠期糖尿病发生率:273/1802(15.1%) vs 136/473(28.8%),aOR 0.49,95%CI 0.38-0.63。
  • 32周前早产发生率:5/1802(0.3%) vs 33/473(7.0%),aOR 0.04,95%CI 0.01-0.10。
  • 5分钟低Apgar评分发生率:15/1802(0.8%) vs 19/473(4.0%),aOR 0.26,95%CI 0.13-0.56;NICU入住率:338/1797(18.8%) vs 147/462(31.8%),aOR 0.52,95%CI 0.41-0.67。

关键数值与推荐

  • 早期启动LDA(12周前)与晚期启动(12至20周)相比,妊娠期高血压aOR 0.24(95%CI 0.18-0.33),子痫前期aOR 0.29(95%CI 0.20-0.42)。
  • 妊娠期糖尿病aOR 0.49(95%CI 0.38-0.63),32周前早产aOR 0.04(95%CI 0.01-0.10)。
  • 5分钟低Apgar评分aOR 0.26(95%CI 0.13-0.56),NICU入住aOR 0.52(95%CI 0.41-0.67)。

临床怎么用

  • 对于具有至少两项子痫前期中危因素的孕妇,可考虑在12周前启动低剂量阿司匹林以改善母儿结局。
  • 临床决策时应结合患者个体情况,并注意本研究为回顾性观察性研究。

局限性

  • 本研究为单中心回顾性队列研究,可能存在选择偏倚和混杂因素。
  • 早期启动组与晚期启动组样本量差异较大(1802 vs 473)。
  • 未报告LDA具体剂量及依从性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preeclampsia is thought to originate from abnormal placentation during early pregnancy. Low-dose aspirin (LDA) reduces the risk of preeclampsia, but most clinical guidelines recommend initiation at 12 weeks of gestation because evidence supporting earlier use remains limited. OBJECTIVE: To evaluate whether initiation of LDA before 12 weeks of gestation improves maternal and neonatal outcomes compared with initiation between 12 and 20 weeks among women with multiple moderate-risk factors for preeclampsia. STUDY DESIGN: This retrospective cohort study included singleton pregnancies delivered at ≥20 weeks between 2015 and 2025 at a single academic center. Eligible women had at least two moderate-risk factors for preeclampsia and received daily LDA during pregnancy. Women with high-risk conditions for preeclampsia were excluded. Women were categorized according to aspirin initiation timing: early initiation before 12 weeks (n=1802) and late initiation between 12 and 20 weeks (n=473). Multivariable logistic regression analyses adjusted for maternal age, body mass index, parity, and method of conception. RESULTS: Early aspirin initiation was associated with significantly lower risks of gestational hypertension (110/1802 [6.1%] vs 118/473 [24.9%]; adjusted odds ratio [aOR] 0.24, 95% confidence interval [CI] 0.18-0.33), preeclampsia (75/1802 [4.2%] vs 74/473 [15.6%]; aOR 0.29, 95% CI 0.20-0.42), and gestational diabetes (273/1802 [15.1%] vs 136/473 [28.8%]; aOR 0.49, 95% CI 0.38-0.63). Early initiation was also associated with lower risks of preterm birth before 32 weeks (5/1802 [0.3%] vs 33/473 [7.0%]; aOR 0.04, 95% CI 0.01-0.10). Neonatal outcomes were improved, including lower risks of low Apgar score at 5 minutes (15/1802 [0.8%] vs 19/473 [4.0%]; aOR 0.26, 95% CI 0.13-0.56) and neonatal intensive care unit admission (338/1797 [18.8%] vs 147/462 [31.8%]; aOR 0.52, 95% CI 0.41-0.67). CONCLUSION: Initiation of LDA before 12 weeks of gestation was associated with reduced risks of hypertensive disorders of pregnancy, preterm birth, and neonatal morbidity compared with initiation between 12 and 20 weeks.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Lee JY, Kim H, Kang YE, et al. Early initiation of low-dose aspirin before 12 weeks improves pregnancy outcomes in women with moderate-risk factors for preeclampsia. Am J Obstet Gynecol MFM. 2026. PMID: 42595049. doi:10.1016/j.ajogmf.2026.102089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。